We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 121-140 of 10,000 results
  1. The CHARTER-Ireland trial: can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trial

    Background

    COVID-19 pneumonia is associated with the development of acute respiratory distress syndrome (ARDS) displaying some typical histological...

    John Robert Sheehan, Padraig Calpin, ... David Cosgrave in Trials
    Article Open access 14 September 2022
  2. Effects of Hormone Replacement Therapy on Women's Lung Health and Disease

    This review provides an overview of menopausal hormone therapy and pulmonary disease risk, with a focus on the effect of hormone replacement therapy...

    Efrat Eliyahu, Michael G. Katz, ... Bezalel Arkush in Pulmonary Therapy
    Article Open access 10 October 2023
  3. Role of macrophage-to-myofibroblast transition in chronic liver injury and liver fibrosis

    Background

    Chronic liver injury contributes to liver fibrosis, which is characterized by the excessive deposition of extracellular matrix (ECM)...

    Suhong **a, Yujie Huang, ... **gmei Liu in European Journal of Medical Research
    Article Open access 08 November 2023
  4. Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review

    Background and Objective

    Trastuzumab deruxtecan (T-DXd) is a novel anti-ERBB2 antibody drug conjugate that appears to be associated with an increased...

    Ziad Abuhelwa, Abdurahman Alloghbi, ... Misako Nagasaka in Drugs
    Article Open access 27 June 2022
  5. Systemic sclerosis interstitial lung disease: unmet needs and potential solutions

    Systemic sclerosis (SSc), or scleroderma, is a rare, complex, systemic autoimmune disease of unknown aetiology, characterized by high morbidity and...

    Vasiliki Liakouli, Antonio Ciancio, ... Francesco Ciccia in Nature Reviews Rheumatology
    Article 03 November 2023
  6. Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and Infection

    Purpose of Review

    Although there has been improvement in short-term clinical outcomes for patients following lung transplant (LT), advances have not...

    J.P. Rosenheck, B.C. Keller, ... D.J. Ross in Current Pulmonology Reports
    Article Open access 26 July 2022
  7. A role of STING signaling in obesity-induced lung inflammation

    Background

    It is established that pulmonary disorders are comorbid with metabolic disorders such as obesity. Previous studies show that the stimulator...

    Yong Qi, Zhuhua Wu, ... Yunlei Yang in International Journal of Obesity
    Article Open access 13 February 2023
  8. Anesthesia for lung transplantation in children under 12 years of age: a single center experience of China

    Purpose

    This study aims to provide a comprehensive overview of anesthesia management strategies employed in pediatric lung transplantation.

    ...
    Shengjie Yuan, Yan Zhou, ... Guilong Wang in Anesthesiology and Perioperative Science
    Article Open access 02 April 2024
  9. A cysteine proteinase inhibitor ALLN alleviates bleomycin-induced skin and lung fibrosis

    Background

    Systemic sclerosis (SSc) is a connective tissue disease that is characterized by fibrosis in the skin and internal organs, such as the...

    Hiroshi Kasamatsu, Takenao Chino, ... Minoru Hasegawa in Arthritis Research & Therapy
    Article Open access 25 August 2023
  10. Differences in clinical characteristics and liver injury between patients diagnosed with the Omicron subvariant BA.5.2 and the prototype of SARS-CoV-2: a single center retrospective study

    Background

    The purpose of this study was to investigate the differences between the clinical characteristics and the factors influencing liver injury...

    Jie Li, Qing Zhang, ... ** Tan in BMC Gastroenterology
    Article Open access 08 August 2023
  11. Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets

    Ischemia-reperfusion (I/R) injury paradoxically occurs during reperfusion following ischemia, exacerbating the initial tissue damage. The limited...

    Meng Zhang, Qian Liu, ... **xiang Yuan in Signal Transduction and Targeted Therapy
    Article Open access 08 January 2024
  12. Crosstalk between the JAK2 and TGF-β1 signaling pathways in scleroderma-related interstitial lung disease targeted by baricitinib

    Background and objective

    Systemic sclerosis (SSc) is an immune-mediated rheumatic disease characterized by fibrosis and vascular lesions. Interstitial...

    Dandan Wang, Yimei Wei, ... Jie Zhang in Advances in Rheumatology
    Article Open access 16 May 2023
  13. Roles of airway basal stem cells in lung homeostasis and regenerative medicine

    Airway basal stem cells (BSCs) in the proximal airways are recognized as resident stem cells capable of self-renewing and differentiating to...

    Meirong Wu, **ao**g Zhang, ... Yiming Zeng in Respiratory Research
    Article Open access 13 May 2022
  14. Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice

    Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease characterized by alveolar epithelial cell injury and lung...

    Yang Miao, Yanhua Wang, ... Cheng Yang in BMC Pulmonary Medicine
    Article Open access 22 March 2023
  15. Lung cancer in the emergency department

    Background

    Though decreasing in incidence and mortality in the USA, lung cancer remains the deadliest of all cancers. For a significant number of...

    Jeremy R. Walder, Saadia A. Faiz, Marcelo Sandoval in Emergency Cancer Care
    Article Open access 06 March 2023
  16. Plumbagin attenuates Bleomycin-induced lung fibrosis in mice

    Background

    Idiopathic pulmonary fibrosis (IPF) is a fatal fibrotic lung disease with limited treatment options. Plumbagin (PL) is an herbal extract...

    Saber Mehdizadeh, Marjan Taherian, ... Nazanin Mojtabavi in Allergy, Asthma & Clinical Immunology
    Article Open access 21 October 2022
  17. An unusual form of kidney injury without glomerulonephritis in microscopic polyangiitis: a case report

    Background

    Microscopic polyangiitis (MPA), a kind of antineutrophil cytoplasmic autoantibody associated vasculitis (AAV), predominantly affects...

    Cihan Uysal, Tugba Yilmaz, ... Murat Hayri Sipahioglu in BMC Nephrology
    Article Open access 31 March 2023
  18. Mechanism of protective effect of xuan-bai-cheng-qi decoction on LPS-induced acute lung injury based on an integrated network pharmacology and RNA-sequencing approach

    Xuan-bai-cheng-qi decoction (XCD), a traditional Chinese medicine (TCM) prescription, has been widely used to treat a variety of respiratory diseases...

    Huahe Zhu, Shun Wang, ... Aidong Yang in Respiratory Research
    Article Open access 28 June 2021
  19. Associations of Wnt5a expression with liver injury in chronic hepatitis B virus infection

    Background

    Aberrant Wnt5a expression contributes to immunity, inflammation and tissue damage. However, it remains unknown whether Wnt5a is associated...

    **ang-Fen Ji, Qi Zhou, ... Kai Wang in BMC Infectious Diseases
    Article Open access 07 December 2023
  20. Basiliximab for early perioperative transplant-associated thrombotic microangiopathy after lung transplantation: a case report

    Background

    Thrombotic microangiopathy is a syndrome characterized by microangiopathic hemolytic anemia and platelet aggregation, which is caused by...

    Naohiro Ijiri, Masaaki Sato, ... Jun Nakajima in Surgical Case Reports
    Article Open access 29 September 2022
Did you find what you were looking for? Share feedback.